How to prove the concerned price if the specialty is not yet produced? What is the value of a proven pricing structure if the price is downsized over time? Lets discuss to overcome this bottleneck.
You dive into a simulation model and at first everything seems flawless. But with each adjustment the risk of flaws creeping into the programming.
How to prove the ‘added value’ when the concerned innovation is beneficial without producing ‘health’ in a direct way?
A model contains a large amount of inputs and every single input will be surrounded with uncertainty and the end result will be a translation of the composite effect of all inputs and their potential variance.
Do you understand the potential impact of using 2 independent datasets? In this blog, we provide you a taste of some basic insights.
Always wondered how health economic models work? Good news: this blog is developed to guide you through the basic elements of ‘health state transition models’.
